Calendar

Upcoming trial readouts

Estimated primary-completion dates sourced from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates: they can and do move as trials progress.

Near-term phase 3

  • August 2026BexicaserinEpilepsy · H. Lundbeck
  • August 2026CamizestrantHR+/HER2- Metastatic Breast Cancer · AstraZeneca
  • August 2026PalbociclibHR+/HER2- Metastatic Breast Cancer · Pfizer
  • August 2026stapokibartAtopic Dermatitis · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
  • August 2026ElranatamabMultiple Myeloma · Pfizer
  • August 2026efsubaglutide alfaObesity · Shanghai Yinnuo Pharmaceutical Technology
Research

Unlock the complete readout calendar

Research includes all upcoming registry events, study-level detail and filters across phase, company, indication and date.

Educational data tool. Earnings dates cover US-listed companies only; no forward earnings date is sourced for foreign-only listings.